SEC Company Response from Enliven Therapeutics, Inc. (ELVN) (CIK 0001672619) (ELVN) — Mar 9, 2020
Enliven Therapeutics, Inc. (ELVN) (CIK 0001672619)
Date: March 9, 2020 · CIK: 0001672619 · Accession: 0001193125-20-067085
AI Filing Summary & Sentiment
File numbers found in text: 333-236465
Letter
IMARA Inc.
116 Huntington Avenue, 6th Floor
Boston, MA 02116
March 9,
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Tonya K. Aldave
Re:
IMARA Inc.
Registration Statement on Form S-1
File No. 333-236465
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, IMARA Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-236465), as amended, so that it may become effective at 4:00 p.m. Eastern time on March 11, 2020, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff of the Securities and Exchange Commission.
[Remainder of Page Intentionally Left Blank]
Very truly yours,
IMARA Inc.
Show Raw Text
CORRESP 1 filename1.htm CORRESP IMARA Inc. 116 Huntington Avenue, 6th Floor Boston, MA 02116 March 9, 2020 VIA EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Tonya K. Aldave Re: IMARA Inc. Registration Statement on Form S-1 File No. 333-236465 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, IMARA Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-236465), as amended, so that it may become effective at 4:00 p.m. Eastern time on March 11, 2020, or as soon thereafter as practicable, or at such later time as the Registrant or its counsel may orally request via telephone call to the staff of the Securities and Exchange Commission. [Remainder of Page Intentionally Left Blank] Very truly yours, IMARA Inc. By: /s/ Rahul D. Ballal Name: Rahul D. Ballal, Ph.D. Title: President and Chief Executive Officer